Web-based survey of physicians' perceptions and actual conditions of agitation associated with Alzheimer's disease.

Web-based survey of physicians' perceptions and actual conditions of agitation associated with Alzheimer's disease. - Survey of physicians' perceptions of Alzheimer's agitation.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055876

Enrollment

500

Registered

2024-10-18

Start date

2024-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Psychiatrist, Neurologist, Neurosurgeon, General Physician Physicians who have treated at least 10 AD patients in the last 1 month

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
1. physician background information - Gender, age, department, number of beds, type of facility, physician's professional qualifications and affiliations 2. actual condition of AD patient care -Number of AD patients and all patients in the last month, type of treatment for AD patients in the last month, medical coordination, names of drug classes and their ranking of newly prescribed drugs for AD patients, reasons for not newly prescribing antipsychotic drugs for AD patients (in Japanese). 3. recognition of BPSD Recognition of BPSD rating scales and definitions, frequency of use of BPSD rating scales, frequency of BPSD occurrence in AD patients, types and ranking of BPSDs reported as difficult to cope with by caregivers of AD patients, BPSDs difficult to cope with and their ranking 4. recognition of AAD Symptoms recalled by "agitation",number of patients with AAD treated in the last month 5. antipsychotic prescriptions Frequency of prescribing for AAD, reasons for not prescribing for AAD, average duration of prescriptions, criteria for starting prescriptions, importance of prescribing and its ranking, side effects of concern and its ranking, prescribing policy when symptoms are stable, explanation to caregivers, evaluation of effectiveness of antipsychotic drugs, discontinuation Reasons for discontinuation	—

Measure

Time frame

1. physician background information - Gender, age, department, number of beds, type of facility, physician's professional qualifications and affiliations 2. actual condition of AD patient care -Number of AD patients and all patients in the last month, type of treatment for AD patients in the last month, medical coordination, names of drug classes and their ranking of newly prescribed drugs for AD patients, reasons for not newly prescribing antipsychotic drugs for AD patients (in Japanese). 3. recognition of BPSD Recognition of BPSD rating scales and definitions, frequency of use of BPSD rating scales, frequency of BPSD occurrence in AD patients, types and ranking of BPSDs reported as difficult to cope with by caregivers of AD patients, BPSDs difficult to cope with and their ranking 4. recognition of AAD Symptoms recalled by "agitation",number of patients with AAD treated in the last month 5. antipsychotic prescriptions Frequency of prescribing for AAD, reasons for not prescribing for AAD, average duration of prescriptions, criteria for starting prescriptions, importance of prescribing and its ranking, side effects of concern and its ranking, prescribing policy when symptoms are stable, explanation to caregivers, evaluation of effectiveness of antipsychotic drugs, discontinuation Reasons for discontinuation

—

Countries

Japan

Contacts

Public ContactKoichi Shimizu

Otsuka Pharmaceutical Co.,Ltd. Medical Affairs

Shimizu.Kochi@otsuka.jp03-6717-1400

Outcome results